Sentiment on the ground isn't meshing with the official data when it comes to inflation.» Read More
The company has been working on keeping customers who switched to its stores during an impasse between larger drugstore rival Walgreen Co and pharmacy benefits manager competitor Express Scripts Holding Co.. Walgreen did not fill Express Scripts prescriptions from the beginning of the year until mid-September.
NEW YORK, Nov 6- U.S. stock index futures pointed to a higher open on Tuesday, putting the S&P 500 on track for a second straight advance as Americans went to the polls to elect the country's president.
NEW YORK, Nov 6- U.S. stock index futures edged higher on Tuesday, indicating the S&P 500 would advance for a second consecutive session with voters set to elect the country's president.
Nov 5- U.S. pharmacy benefits manager Express Scripts Holding Co said analyst forecasts for its 2013 results were too aggressive, casting doubt on how well it is integrating its $29 billion purchase of Medco Health Solutions Inc and sending its shares down 14 percent.
WASHINGTON-- The Department of Justice said Monday that a unit of CVS Caremark Corp. has agreed to pay $5.25 million to settle allegations that it reported false information on prescription drug prices to the government's Medicare program.
Cramer makes the call on viewers' favorite stocks.
CNBC's David Faber reports on the agreement between Express Scripts and Walgreen, and weighs in on Verizon's earnings.
The "Squawk on the Street" news crew weighs in on a new pharmacy network agreement reached between Express Script and Walgreen. Stock in both companies jumped higher on the announcement.
Arthur Hogan, MD & Head of Product Strategy at Lazard Capital Markets thinks the euro zone will eventually get more good news than bad news. He adds the risk right now is to be positioned against that eventuality.
CNBC's David Faber reports Walgreens comparable sales are down 5.8% from a year ago.
David Kostin, chief U.S. equity strategist at Goldman Sachs, weighs in on which stocks he thinks matter the most, including Apple, Google and Microsoft.
CNBC's Brian Shactman reports under the radar stocks investors should keep an eye on.
CNBC's Herb Greenberg has the story on a big battle brewing over where prescriptions are filled and how much you are going to pay, with Mark Merritt, PCMA president & CEO, and David Balto, antitrust attorney.
The Fast Money traders have the play on Limited Brands.
Deborah Weinswig, Citi analyst, defends her downgrade of WAG, on the heels of its big fight with Express Scripts, with the Fast Money traders.
Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health are growing, with CNBC's Bertha Coombs.
CNBC's David Faber reports on the battle between Walgreens and pharmacy benefit manager, Express Scripts.